Risk factors for deep sternal wound infection after cardiac surgery: Influence of red blood cell transfusions and chronic infection

American Journal of Infection Control

Volumn 44, Issue 11, 2016, Pages 1302-1309

  Cutrell, James B ^a,b   Barros, Nicolas ^a,c   McBroom, Mandy ^a   Luby, James ^a,c   Minhajuddin, Abu ^a   Ring, W Steves ^a   Greilich, Philip E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c PARKLAND HEALTH AND HOSPITAL SYSTEM   (United States)

Author keywords

Anemia; Antibiotic prophylaxis; Prevention; Surgical site infection

Indexed keywords

CEFUROXIME; VANCOMYCIN;

ADULT; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL ENDOCARDITIS; BARTONELLOSIS; CARDIOVASCULAR INFECTION; CASE CONTROL STUDY; CHRONIC DISEASE; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP STERNAL WOUND INFECTION; DEVICE INFECTION; DISEASE ASSOCIATION; DRIVELINE INFECTION; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KLEBSIELLA PNEUMONIAE INFECTION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIDDLE AGED; PREOPERATIVE PERIOD; RISK ASSESSMENT; RISK FACTOR; STERNUM; SURGICAL INFECTION; SYPHILIS; THROMBOCYTE TRANSFUSION; AGED;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CASE-CONTROL STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 84970025029     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2016.03.027     Document Type: Article

References (30)

1. 1 Fowler, V.G., O'Brien, S.M., Muhlbaier, L.H., Corey, G.R., Ferguson, B., Peterson, E.D., Clinical predictors of major infections after cardiac surgery. Circulation 112 (2005), I358–65.
2. 2 Shahian, D.M., O'Brien, S.M., Filardo, G., Ferraris, V.A., Haan, C.K., Rich, J.B., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg 88 (2009), S2–22.
3. 3 Filsoufi, F., Rahmanian, P.B., Castilla, J.G., Pinney, S., Broumand, S.R., Adams, D.H., Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. J Heart Lung Transplant 26 (2007), 1084–1090.
4. 4 Haley, V.B., Van Antwerpen, C., Tsivitis, M., Doughty, D., Gase, K.A., Hazamy, P., et al. Risk factors for coronary artery bypass graft chest surgical site infections in New York State, 2008. Am J Infect Control 40 (2012), 22–28.
5. 5 Kubota, H., Miyata, H., Motomura, N., Ono, M., Takamoto, S., Harii, K., et al. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg 8 (2013), 1–6.
6. 6 Buja, A., Zampieron, A., Cavalet, S., Chiffi, D., Sandonà, P., Vinelli, A., et al. An update review on risk factors and scales for prediction of deep sternal wound infections. Int Wound J 9 (2012), 372–386.
7. 7 Robinson, P.J., Billah, B., Leder, K., Reid, C.M., Factors associated with deep sternal wound infection and haemorrhage following cardiac surgery in Victora. Interact Cardiovasc Thorac Surg 6 (2007), 167–171.
8. 8 Crabtree, T.D., Codd, J.E., Fraser, V.J., Bailey, M.S., Olsen, M.A., Damiano, R.J. Jr, Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center. Semin Thorac Cardiovasc Surg 16 (2004), 53–61.
9. 9 Ariyaratnam, P., Bland, M., Loubani, M., Risk factors and mortality associated with deep sternal wound infections following coronary artery bypass surgery with or without concomittant procedures in a UK population: a basis for a new risk model?. Interact Cardiovasc Thorac Surg 11 (2010), 543–546.
10. 10 Graf, K., Ott, E., Vonberg, R.P., Kuehn, C., Haverich, A., Chaberny, I.F., Economic aspects of deep sternal wound infections. Eur J Cardiothorac Surg 37 (2010), 893–896.
11. 11 O'Brien, S.M., Shahian, D.M., Filardo, G., Ferraris, V.A., Haan, C.K., Rich, J.B., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 88 (2009), S23–42.
12. 12 Shahian, D.M., O'Brien, S.M., Filardo, G., Ferraris, V.A., Haan, C.K., Rich, J.B., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3- valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 88 (2009), S43–62.
13. 13 CDC, CDC/NHSN Surveillance Definitions for Specific Types of Infections. 2015, Centers for Disease Control and Prevention, Atlanta, GA.
14. 14 Carson, J.L., Carless, P.A., Hebert, P.C., Transfusion thresholds and other strategies for guiding allogenic red blood cell transfusion. Cochrane Database Syst Rev(4), 2012 CD002042.
15. 15 Carson, J.L., Terrin, M.L., Noveck, H., Sanders, D.W., Chaitman, B.R., Rhoads, G.G., et al. Liberal of restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365 (2011), 2453–2462.
16. 16 Hajjar, L.A., Vincent, J.L., Galas, F.R., Nakamura, R.E., Silva, C.M., Santos, M.H., et al. Transfusion requirements after cardiac surgery. The TRACS randomized controlled trial. JAMA 304 (2010), 1559–1567.
17. 17 Banbury, M.K., Brizio, M.E., Rajeswaran, J., Lytle, B.W., Blackstone, E.H., Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 202 (2006), 131–138.
18. 18 Horvath, K.A., Acker, M.A., Chang, H., Bagiella, E., Smith, P.K., Iribarne, A., et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 95 (2013), 2194–2201.
19. 19 Baryshnikova, R.M., Castelvecchio, S., Pelissero, G., Surgical and Clinical Outcome Research (SCORE) Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 96 (2013), 478–485.
20. 20 Koch, C.G., Li, L., Duncan, A.I., Mihaljevic, T., Cosgrove, D.M., Loop, F.D., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 (2006), 1608–1616.
21. 21 Ferraris, V.A., Davenport, D.L., Saha, S.P., Austin, P.C., Zwischenberer, J.B., Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg 147 (2012), 49–55.
22. 22 Murphy, G.J., Pike, K., Rogers, C.A., Wordsworth, S., Stokes, E.A., Angelini, G.D., et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372 (2015), 997–1008.
23. 23 Li, J., Wu, W., Peng, G., Chen, F., Bai, M., Zheng, M., et al. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol 88 (2010), 834–841.
24. 24 Miroux, C., Vausselin, T., Delhem, N., Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response. Expert Opin Biol Ther 10 (2010), 1563–1572.
25. 25 Peng, G., Li, S., Wu, W., Sun, Z., Chen, Y., Chen, Z., Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology 123 (2008), 57–65.
26. 26 Sousa, R., Munoz-Mahamud, E., Quayle, J., Dias da Costa, L., Casals, C., Scott, P., et al. Is asymptomatic bacteriuria a risk factor for prosthetic joint infection?. Clin Infect Dis 59 (2014), 41–47.
27. 27 Mastoraki, S., Michaelopoulos, A., Kriaras, I., Geroulanos, S., Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery. Interact Cardiovasc Thorac Surg 6 (2007), 442–446.
28. 28 Teillant, A., Gandra, S., Barter, D., Morgan, D.J., Laxminarayan, R., Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 15 (2015), 1429–1437.
29. 29 Manian, F.A., The role of postoperative factors in surgical site infections: time to take notice. Clin Infect Dis 59 (2014), 1272–1276.
30. 30 Petherick, E.S., Dalton, J.E., Moore, P.J., Cullum, N., Methods for identifying surgical wound infection after discharge from hospital: a systematic review. BMC Infect Dis, 6, 2006, 170.